Given that it has been reported that IL-18 counteracts the pro-inflammatory activities of IL-1β, thereby balancing control of H. pylori infection and prevention of excessive gastric immunopathology [10], it could be postulated that down-regulation of IL18 contributes to the increased inflammation associated with GC. The gene discussed is IL18; the disease is gastric cancer.